Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 10 of 22
Film-Coated Tablet
Etoricoxib 120 mg Film-Coated Tablet is a film-coated tablet formulated with 120 mg. The active ingredient profile is Etoricoxib, placing the product in the selective cox-2 nsaid category. The formulation contains an NSAID and/or non-opioid analgesic comp
Film-Coated Tablet
Etoricoxib 60 mg + Paracetamol 325 mg Film-Coated Tablet is a film-coated tablet formulated with Etoricoxib 60 mg + Paracetamol 325 mg. The active ingredient profile is Etoricoxib; Paracetamol, placing the product in the cox-2 nsaid + analgesic combinatio
Film-Coated Tablet
Faropenem Sodium 200 mg + Potassium Clavulanate Eq. to Clavulanic Acid 125 mg Film-Coated Tablet is a film-coated tablet formulated with Faropenem Sodium 200 mg + Potassium Clavulanate equivalent to Clavulanic Acid 125 mg. The active ingredient profile is
Film-Coated Tablet
Flavoxate 20 mg Film-Coated Tablet IP is a film-coated tablet formulated with 20 mg. The active ingredient profile is Flavoxate, placing the product in the urinary antispasmodic category. Flavoxate is a urinary antispasmodic used for symptomatic relief of
Film-Coated Tablet
Flavoxate HCl 200 mg + Ofloxacin 200 mg Film-Coated Tablet is a film-coated tablet formulated with Flavoxate HCl 200 mg + Ofloxacin 200 mg. The active ingredient profile is Flavoxate HCl; Ofloxacin, placing the product in the urinary antispasmodic + antib
Capsule
Fluconazole 150mg Capsule is a capsule formulated with Fluconazole 150mg. The listed active ingredient profile is Fluconazole, placing the product in the antifungal category. The active ingredient is an antifungal medicine used against susceptible fungal
Oral Suspension / Dry Syrup
Fluconazole 200mg/5ml Oral Suspension is a oral suspension / dry syrup formulated with Fluconazole 200mg/5ml. The listed active ingredient profile is Fluconazole, placing the product in the antifungal category. The active ingredient is an antifungal medic
Oral Suspension / Dry Syrup
Fluconazole 50mg5ml Oral Suspension is a oral suspension / dry syrup formulated with Fluconazole 50mg5ml. The listed active ingredient profile is Fluconazole 50mg5ml, placing the product in the antifungal category. The active ingredient is an antifungal m
Uncoated Bilayered Tablet
Flupirtine Maleate 100 mg + Paracetamol 325 mg Uncoated Bilayered Tablet is a uncoated bilayered tablet formulated with Flupirtine Maleate 100 mg + Paracetamol 325 mg. The active ingredient profile is Flupirtine Maleate; Paracetamol, placing the product i
Topical Formulation
Fusidic Acid 20mg is a topical formulation formulated with Fusidic Acid 20mg. The listed active ingredient profile is Fusidic Acid, placing the product in the topical antibacterial / dermatology category. The formulation contains topical antibacterial ing
Cream
Fusidic Acid IP 20 mg Cream is a cream formulated with Fusidic Acid IP 20 mg. The listed active ingredient profile is Fusidic Acid, placing the product in the topical antibacterial / dermatology category. The formulation contains topical antibacterial ing
Capsule
Gabapentin 100mg Capsules is a capsule formulated with Gabapentin 100mg. The listed active ingredient profile is Gabapentin, placing the product in the neuropathic pain / neuro-nutritional category. The formulation contains neuropathic-pain and/or neuro-n
Dosage form on request
Broad-spectrum APIs spanning CNS, cardiovascular, urology, and metabolic indications — plus enzyme and biologic preparations. Supplied in pharmaceutical grade for diverse formulation manufacturing across primary and specialty care product lines.
Topical Formulation
Gentamicin Sulphate 0.1%w/w is a topical formulation formulated with Gentamicin Sulphate 0.1%w/w. The listed active ingredient profile is Gentamicin Sulphate w/w, placing the product in the topical antibacterial / dermatology category. The formulation con
Tablet
Gliclazide 80mg + Metformin hydrochloride 500mg Tablets (Uncoated Blayered) is a tablet formulated with Gliclazide 80mg + Metformin hydrochloride 500mg ( Blayered). The listed active ingredient profile is Gliclazide; Metformin hydrochloride, placing the p
Tablet
Gliclozide 80mg + Metformin hydrochloride 800mg Tablets (enterlc coated) is a tablet formulated with Gliclozide 80mg + Metformin hydrochloride 800mg (enterlc coated). The listed active ingredient profile is Gliclozide; Metformin hydrochloride, placing the
Bilayered Tablet
Glimepiride 2mg + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg + Metformin HCI (SR) 500mg . ( ). The listed active ingredient profile is Glimepiride; Metformin HCI, placing the product in the ora
Bilayered Tablet
Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg IP ( ). The listed active ingredient profile is Glimepiride; Metf
Tablet
Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered) is a tablet formulated with Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered). The listed active ingredient profile is Glimepiride; Metformin
Tablet
Glimepiride 2mg Tab. (Uncoated) is a tablet formulated with Glimepiride 2mg . ( ). The listed active ingredient profile is Glimepiride, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medic
Bilayered Tablet
Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg ( ). The listed active ingredient pr
Bilayered Tablet
Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg Tablets (uncoted bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg (uncoted ). The listed acti
Bilayered Tablet
Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg Tablets (uncoted bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg (uncoted ). The listed acti
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
